• #1056253
  • 64
  • Fidia Pharma USA Inc #89122049663
Hymovis® High Molecular Weight Viscoelastic Hyaluronan 8 mg / mL Intra-articular Injection Prefilled Syringe 3 mL

Features
  • HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen)
  • HYMOVIS® is a sterile, non-pyrogenic, viscoelastic hydrogel contained in a single-use syringe
  • HYMOVIS® has a hyaluronan (HYADD®4) concentration of 8 mg/mL, dissolved in physiologic saline
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #1056253
Manufacturer #89122049663
BrandHymovis®
ManufacturerFidia Pharma USA Inc
Country of OriginUnited States
ApplicationOsteoarthritis Agent
Container TypePrefilled Syringe
Dosage FormInjection
Generic Drug NameHigh Molecular Weight Viscoelastic Hyaluronan
NDC Number89122-0496-63
Storage RequirementsUSP Controlled Room Temperature
Strength8 mg / mL
TypeIntra-articular
UNSPSC Code51202002
Volume3 mL
Features
  • HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen)
  • HYMOVIS® is a sterile, non-pyrogenic, viscoelastic hydrogel contained in a single-use syringe
  • HYMOVIS® has a hyaluronan (HYADD®4) concentration of 8 mg/mL, dissolved in physiologic saline
  • HYMOVIS® is supplied in a set of 2 single-use 5 mL syringes, each containing a 3 mL dose of treatment to be injected one week apart